FRIDAY, JULY 21, 2017

Janssen Pharmaceutical leader says collaborations are critical in fight against HIV

HIV does not have one solution, which makes scientific collaborations vital for developing treatments and vaccines. Read More »

Experimental Ebola treatment trial shows inconclusive results

A non-randomized, multi-centered study evaluating favipiravir in treating 126 patients who had Ebola infections had inconclusive results. Read More »

3-D protein map may help scientists develop malaria vaccine

Researchers at the Walter and Eliza Hall Institute recently developed the world’s first 3-D map of a protein that could prove crucial to identifying malaria parasites as they attack human red blood cells and spread throughout the body. Read More »

ViiV Healthcare releases study results of HIV inhibitor

ViiV Healthcare, GSK's worldwide HIV specialist, recently released the positive results from its 41-week Phase IIa ÉCLAIR study to determine the tolerability, safety, satisfaction and dosing of an investigational monotherapy for potential HIV patients. Read More »

Nigerian officials conduct door-to-door visits to manage polio

Health care workers in Nigeria are conducting door-to-door visits among local residents to ensure Nigerians have received their polio vaccinations, as health professionals believe this will manage the disease's spread. Read More »

EU officials offer mid-season flu assessment

A mid-seasonal influenza risk assessment shows that type A viruses, especially A(H1N1)pdm09, are the dominant strains for European Union countries this year. Read More »

Patient files to block patents for two HIV drugs

Doctors Without Borders (MSF) and an HIV patient in India recently filed an application to block ViiV Healthcare from receiving patents for two new important HIV drugs. Read More »

Hong Kong officials issue update on dengue fever

Officials with Hong Kong's Center for Health Protection (CHP) recently released a report with the latest figures for dengue fever cases. Read More »

Real-time system monitors Ebola through a microscope

Scientists recently published an article in mBio, a journal from the American Society for Microbiology, that suggests the first real-time system can monitor Ebola through a microscope while the Ebola-like virus particles infect and bond with human cells. Read More »

Johns Hopkins researchers identify TB's natural resistance to antibiotics

Johns Hopkins University School of Medicine biophysicists recently found that the bacteria causing tuberculosis (TB) may be naturally resistant to antibiotics, called fluoroquinolones, which could help researchers strengthen TB drugs that have weakened over time. Read More »

CDC adds eight countries to Zika virus travel guidelines

The Centers for Disease Control and Prevention (CDC) recently added new countries to its travel guidelines concerning the Zika virus, warning people who travel to these regions that the virus is at large. Read More »

Rotary International invests $35 million in polio elimination

Rotary International recently invested $35 million in grants to various immunization activities and research projects that are designed to eliminate polio from the world health scene. Read More »

WHO authorizes additional cholera vaccine supplies to stop worldwide shortage

The World Health Organization (WHO) recently approved an additional producer for the oral cholera vaccine, intending to resolve worldwide shortages of the vaccine by doubling the supply and extending service throughout more areas. Read More »

Study reveals HIV targets tissue macrophages

A team of researchers in the Division of Infectious Diseases at the University of North Carolina School of Medicine recently found that human immunodeficiency virus (HIV) infections target tissue macrophages, which are large white blood cells located in the brain, liver and connective tissues. Read More »

More than 2 million people have HIV and hepatitis C co-infections

A recent study from the University of Bristol and the London School of Hygiene & Tropical Medicine found that approximately 2.3 million people around the world have co-infections of human immunodeficiency virus (HIV) and hepatitis C (HCV). Read More »

NIAID's HOPE study looks at dapivirine vaginal rings to prevent HIV

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), will proceed with the HIV Open-label Prevention Extension (HOPE) Phase 3B trial to study the use of a dapivirine vaginal ring to prevent HIV in women.  Read More »

New biochip may provide fast, accurate HIV diagnosis

A new, differential immuno-capture biochip, created by researchers from the University of Illinois at Urbana-Champaign, is able to provide specific leukocyte counts that will help health professionals make a more accurate diagnosis of HIV infections. Read More »

Preventive efforts reduce pediatric HIV infection in Nigeria study

A recent study of mother-to-child transmissions of human immunodeficiency virus (HIV) infections, the disease that causes AIDS, in Nigeria found that preventive health-care intervention measures helped reduce infections. Read More »

New test may decrease TB death rates for HIV patients in sub-Saharan Africa

A team of scientists have developed a cost-efficient, simple, 25-minute urine test that diagnoses tuberculosis (TB) in HIV patients, which may be able to decrease the TB death rates among these patients in hospitals. Read More »

New regimen reduces drug-resistant malaria severity during pregnancy

A recent study funded by the National Institutes of Health and conducted in Uganda found that a new treatment regimen involving two drugs may be able to reduce the severity of drug-resistant malaria during pregnancy. Read More »